Postprocedure Intravenous Eptifibatide Following Intra‐Arterial Reteplase in Patients with Acute Ischemic Stroke

Abstract

The use of intravenous eptifibatide within 24 hours in selected patients after IA thrombolysis is feasible and safe. Further studies are required to determine the benefit of early use of intravenous eptifibatide following thrombolysis.